Nikkei Asia: Delays on WTO deal for COVID treatments are costing lives in Asia
December 14, 2022 — In Nikkei Asia, Rethink Trade Director Lori Wallach and Joseph Stiglitz explain how the WTO's delay in allowing the export of generic COVID treatments is costing lives across Asia.
Scientific American: The International Community Must Prioritize COVID Treatment and Test Access | Opinion
November 14, 2022 — In Scientific American, Rethink Trade Director Lori Wallach and Joseph Stiglitz urge the international trade community to make COVID-19 treatments and tests more accessible.
Newsweek: WTO Cannot Continue as Barrier to COVID-19 Medicines | Opinion
June 10, 2022 — In Newsweek, Rethink Trade Director Lori Wallach partners with Nobel Laureate and Columbia University Professor Joseph Stiglitz to spotlight the crisis at the WTO as they holds its first summit in five years.